Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy

NCT04846673 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathy

Interventions

DRUG: Pregabalin 150mg + Alpha-lipoic acid 480mg
DRUG: Pregabalin 150mg
DRUG: Alpha-Lipoic Acid 480mg

Sponsor

Yuhan Corporation